Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Hungary

Coordination and Support Action · Running

IDP2Biomed Bringing Intrinsically Disordered Proteins to Biomedical Applications

Coordinator
Eotvos Lorand Tudomanyegyetem, Hungary
Runs
1 October 2024 to 30 September 2027
Status
Running
EU funding
€1.2m
Total cost
—
Partners
4 organisations in 4 countries
Type
Coordination and Support Action
Grant agreement
101160233

What the project is doing

In the project's own words, from its summary on CORDIS.

The IDP2Biomed twinning program is aimed at strengthening the scientific excellence and innovation capacity at the interface between Chemistry and Biology of the Faculty of Science of Eötvös Loránd University (ELTE). Researchers from ELTE will be working closely together with three leading European research groups in the field of intrinsically disordered proteins (IDPs). This partnership will provide an ideal platform to enable ELTE to increase its ability to generate scientific innovation and clinical translation.

This objective will be achieved by focusing on IDPs that are directly involved in diseases with great socio-economic importance, such as neurodegenerative diseases and rare diseases. IDP2Biomed will integrate IDP-related information with biomedical data, advance the understanding of the function of IDPs in normal and disease states and explore new avenues to alter their behaviour in pathological states. The impact of this program will be maximised by fostering cooperation with academic and industrial partners locally and across the EU.

Topics

Who is involved

OrganisationCityCountryRole
Eotvos Lorand TudomanyegyetemBudapestHungaryCoordinator
Deutsches Zentrum Fur Neurodegenerative Erkrankungen eVBonnGermanyParticipant
Universita Degli Studi Di PadovaPadovaItalyParticipant
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI